The new biology and pharmacology of glucagon
TD Müller, B Finan, C Clemmensen… - Physiological …, 2017 - journals.physiology.org
In the last two decades we have witnessed sizable progress in defining the role of
gastrointestinal signals in the control of glucose and energy homeostasis. Specifically, the …
gastrointestinal signals in the control of glucose and energy homeostasis. Specifically, the …
The importance of β-cell failure in the development and progression of type 2 diabetes
SE Kahn - The Journal of Clinical Endocrinology & Metabolism, 2001 - academic.oup.com
The pathogenesis of type 2 diabetes is complex and in most instances clearly requires
defects in both ß-cell function and insulin sensitivity (1). Together, these abnormalities result …
defects in both ß-cell function and insulin sensitivity (1). Together, these abnormalities result …
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
A Lorenzo, B Razzaboni, GC Weir, BA Yankner - Nature, 1994 - nature.com
THE 37-amino-acid polypeptide amylin is the principal constituent of the amyloid deposits
that form in the islets of Langerhans in patients with type-2 diabetes mellitus1–5, but its role …
that form in the islets of Langerhans in patients with type-2 diabetes mellitus1–5, but its role …
Vascular actions of calcitonin gene-related peptide and adrenomedullin
SD Brain, AD Grant - Physiological reviews, 2004 - journals.physiology.org
This review summarizes the receptor-mediated vascular activities of calcitonin gene-related
peptide (CGRP) and the structurally related peptide adrenomedullin (AM). CGRP is a 37 …
peptide (CGRP) and the structurally related peptide adrenomedullin (AM). CGRP is a 37 …
Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis
Abstract Type 2 diabetes (T2DM) is characterized by insulin resistance, defective insulin
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes
RL Hull, GT Westermark, P Westermark… - The Journal of clinical …, 2004 - academic.oup.com
Islet amyloid deposition is a pathogenic feature of type 2 diabetes, and these deposits
contain the unique amyloidogenic peptide islet amyloid polypeptide. Autopsy studies in …
contain the unique amyloidogenic peptide islet amyloid polypeptide. Autopsy studies in …
Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells
SE Kahn, DA D'Alessio, MW Schwartz, WY Fujimoto… - Diabetes, 1990 - Am Diabetes Assoc
Islet amyloid polypeptide (IAPP) has been identified as the major constituent of the
pancreatic amyloid of non-insulin-dependent diabetes mellitus (NIDDM) and is also present …
pancreatic amyloid of non-insulin-dependent diabetes mellitus (NIDDM) and is also present …
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
SE Kahn, S Andrikopoulos, CB Verchere - Diabetes, 1999 - Am Diabetes Assoc
Islet amyloid has been recognized as a pathological entity in type 2 diabetes since the turn
of the century. It has as its unique component the islet beta-cell peptide islet amyloid …
of the century. It has as its unique component the islet beta-cell peptide islet amyloid …
Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors
D Van Rossum, UK Hanisch, R QUIRION - Neuroscience & Biobehavioral …, 1997 - Elsevier
VAN ROSSUM, DU-K. HANISCH AND R. QUIRION. Neuroanatomical localization,
pharmacological characterization and functions of CGRP, related peptides and their …
pharmacological characterization and functions of CGRP, related peptides and their …
Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (∗)
TA Mirzabekov, M Lin, BL Kagan - Journal of Biological Chemistry, 1996 - ASBMB
Amylin is a 37-amino acid cytotoxic constituent of amyloid deposits found in the islets of
Langerhans of patients with type II diabetes. Extracellular accumulation of this peptide …
Langerhans of patients with type II diabetes. Extracellular accumulation of this peptide …